Physician profile
Daniel Wakefield
NPI 1003265539
$8,749.28
in general payments reported to CMS, 2019-2025
16 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.67 · 2022: $145 · 2023: $7,933 · 2024: $491 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,250 · Honoraria: $2,505 · Food and Beverage: $1,362 · Travel and Lodging: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,250.00 |
| Honoraria | $2,505.00 |
| Food and Beverage | $1,361.79 |
| Travel and Lodging | $470.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $4,992.34 | 2023-2024 | |
| Novocure INC. | $2,772.84 | 2022-2024 | Optune |
| Astrazeneca Pharmaceuticals LP | $270.97 | 2023-2024 | Lynparza |
| Gt Medical Technologies, INC | $134.71 | 2023 | Gammatile |
| Exelixis INC. | $130.00 | 2023 | Cabometyx |
| Elekta, INC. | $76.02 | 2022-2023 | Elekta Medical Linear Accelerator |
| Novartis Pharmaceuticals Corporation | $57.52 | 2022-2025 | |
| Siemens Medical Solutions USA, INC. | $56.66 | 2021-2023 | Halcyon |
| Bayer Healthcare Pharmaceuticals INC. | $48.34 | 2023 | |
| Ambu INC. | $45.67 | 2022 | |
| Janssen Biotech, INC. | $45.20 | 2025 | Rybrevant |
| Blue Earth Diagnostics | $37.40 | 2025 | Posluma |
| Daiichi Sankyo INC. | $24.28 | 2025 | |
| Sumitomo Pharma America, INC. | $23.63 | 2024 | Orgovyx |
| Gebauer Company | $19.86 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $13.84 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wakefield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.